Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance.
The annually reformulated trivalent inactivated influenza vaccine (TIV) includes both influenza A/subtypes (H3N2 and H1N1) but only one of two influenza B/lineages (Yamagata or Victoria). In a recent series of clinical trials to evaluate prime-boost response across influenza B/lineages, influenza-na...
Guardado en:
Autores principales: | Danuta M Skowronski, Marie-Eve Hamelin, Naveed Z Janjua, Gaston De Serres, Jennifer L Gardy, Chantal Rhéaume, Xavier Bouhy, Guy Boivin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5478b8680afb4043bad6620fe227c766 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season.
por: Yi-Chun Lo, et al.
Publicado: (2013) -
Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
por: Laura Sánchez-de Prada, et al.
Publicado: (2021) -
Cross-lineage protection by human antibodies binding the influenza B hemagglutinin
por: Yi Liu, et al.
Publicado: (2019) -
Lineage-specific protection and immune imprinting shape the age distributions of influenza B cases
por: Marcos C. Vieira, et al.
Publicado: (2021) -
Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Andrew Chak-Yiu Lee, et al.
Publicado: (2021)